Efficacy and Safety of Tetracyclines in Bone and Joint Infections: A Literature Review
Tetracyclines may provide therapeutic options for refractory or MDR-related BJIs, and for suppressive therapy when surgical or antibiotic alternatives are limited. However, available data are heterogeneous and largely observational. Robust prospective studies are needed to clarify their role, particularly for newer agents such as omadacycline and eravacycline.
Authors
- J. Lavigne
- Albert Sotto
- Agathe Artiaga
- Paul Laffont-Lozes
- Paul Loubet
- Romaric Larcher
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Physiologie et Médecine Expérimentale du Coeur et des Muscles (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Université de Nîmes (FR)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1007/s40121-026-01324-5
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00